Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,535 | -10,326 | -22,931 | -19,718 | -10,611 |
| Depreciation Amortization | 297 | 72 | 195 | 132 | 97 |
| Accounts receivable | 13,620 | 8,965 | -10,413 | 2,655 | 350 |
| Other Working Capital | -12,979 | 2,611 | -3,920 | 6,750 | 364 |
| Other Operating Activity | -9,827 | -7,966 | 14,637 | 471 | 1,724 |
| Operating Cash Flow | $-110,424 | $-6,644 | $-22,432 | $-9,710 | $-8,076 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -23 | -505 | -327 | -201 |
| Investing Cash Flow | $-23 | $-23 | $-505 | $-327 | $-201 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 8,728 | 25,976 | 25,976 |
| Other Financing Activity | 239,038 | -93 | 17,256 | 0 | 0 |
| Financing Cash Flow | $239,038 | $-93 | $25,984 | $25,976 | $25,976 |
| Beginning Cash Position | 35,778 | 35,778 | 32,731 | 32,731 | 32,731 |
| End Cash Position | 164,369 | 29,018 | 35,778 | 48,670 | 50,430 |
| Net Cash Flow | $128,591 | $-6,760 | $3,047 | $15,939 | $17,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,424 | -6,644 | -22,432 | -9,710 | -8,076 |
| Capital Expenditure | -23 | -23 | -505 | -327 | -201 |
| Free Cash Flow | -110,447 | -6,667 | -22,937 | -10,037 | -8,277 |